302 related articles for article (PubMed ID: 32899428)
21. YY1-Activated Long Noncoding RNA SNHG5 Promotes Glioblastoma Cell Proliferation Through p38/MAPK Signaling Pathway.
Chen L; Gong X; Huang M
Cancer Biother Radiopharm; 2019 Nov; 34(9):589-596. PubMed ID: 31657621
[No Abstract] [Full Text] [Related]
22. Yin-Yang-1 decreases Fas-induced apoptosis in acute lymphoblastic leukemia under hypoxic conditions: its implications in immune evasion.
Martínez-Torres E; López-Pérez TV; Morales-Martínez M; Huerta-Yepez S
Bol Med Hosp Infant Mex; 2020; 77(4):186-194. PubMed ID: 32713953
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
Bonavida B
Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
[TBL] [Abstract][Full Text] [Related]
24. The involvement of the transcription factor Yin Yang 1 in cancer development and progression.
Castellano G; Torrisi E; Ligresti G; Malaponte G; Militello L; Russo AE; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2009 May; 8(9):1367-72. PubMed ID: 19342874
[TBL] [Abstract][Full Text] [Related]
25. Yin yang 1 expression in human tumors.
Zaravinos A; Spandidos DA
Cell Cycle; 2010 Feb; 9(3):512-22. PubMed ID: 20081375
[TBL] [Abstract][Full Text] [Related]
26. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
28. Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity.
Wu B; Li P; Qiu E; Chen J
BMC Pharmacol Toxicol; 2023 Oct; 24(1):50. PubMed ID: 37828612
[TBL] [Abstract][Full Text] [Related]
29. Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cells.
Zhang JJ; Zhu Y; Yang C; Liu X; Peng YP; Jiang KR; Miao Y; Xu ZK
Oncotarget; 2016 May; 7(19):28498-509. PubMed ID: 27074573
[TBL] [Abstract][Full Text] [Related]
30. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.
Qian S; Wang W; Li M
Biomed Pharmacother; 2020 Jun; 126():110085. PubMed ID: 32199224
[TBL] [Abstract][Full Text] [Related]
32. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia.
Antonio-Andres G; Martinez-Ruiz GU; Morales-Martinez M; Jiménez-Hernandez E; Martinez-Torres E; Lopez-Perez TV; Estrada-Abreo LA; Patino-Lopez G; Juarez-Mendez S; Davila-Borja VM; Huerta-Yepez S
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163649
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate.
Sieber S; Gdynia G; Roth W; Bonavida B; Efferth T
Int J Oncol; 2009 Jul; 35(1):149-58. PubMed ID: 19513562
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile.
Lorenzetti MA; Mosna MJ; De Matteo EN; García Lombardi M; Colli SL; Preciado MV
Exp Mol Pathol; 2019 Jun; 108():24-31. PubMed ID: 30876863
[TBL] [Abstract][Full Text] [Related]
36. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Bonavida B; Baritaki S
Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional YY1 in Liver Diseases.
Zhang M; Zhang Y; Yang S; Zhou J; Gao W; Yang X; Yang D; Tian Z; Wu Y; Ni B
Semin Liver Dis; 2017 Nov; 37(4):363-376. PubMed ID: 29272897
[TBL] [Abstract][Full Text] [Related]
38. miR-186 reverses cisplatin resistance and inhibits the formation of the glioblastoma-initiating cell phenotype by degrading Yin Yang 1 in glioblastoma.
Li J; Song J; Guo F
Int J Mol Med; 2019 Jan; 43(1):517-524. PubMed ID: 30365062
[TBL] [Abstract][Full Text] [Related]
39. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.
Hays E; Bonavida B
Drug Resist Updat; 2019 Mar; 43():10-28. PubMed ID: 31005030
[TBL] [Abstract][Full Text] [Related]
40. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
